Cholinesterase inhibitors and reduced risk of hospitalization and mortality in patients with Alzheimer's dementia and heart failure
This study suggests that in persons with HF and AD, treatment with ChEIs is associated with improved survival and a decreased risk of hospital care for HF, but results due to the type of ChEI vary.
Authors
- Maria Eriksdotter (ORCID: https://orcid.org/0000-0003-2498-4000)
- Marianne Reimers-Wessberg (ORCID: https://orcid.org/0000-0001-8112-116X)
- Hong Xu (ORCID: https://orcid.org/0000-0002-7266-3431)
- Åke Seiger
- Johan Fastbom (ORCID: https://orcid.org/0000-0001-9656-4668)
Institutions
- Karolinska University Hospital (SE)
- Stockholm University (SE)
- Swedish Foundation for Strategic Research (SE)
- Karolinska Institutet (SE)
- Stockholm South General Hospital (SE)
Publication Details
- Journal
- European Heart Journal - Cardiovascular Pharmacotherapy
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/ehjcvp/pvae091
- Citations
- 5
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.94
Funders
- Svenska Sällskapet för Medicinsk Forskning
- Karolinska Institutet
- Stockholms Läns Landsting
- Vetenskapsrådet
- Medical Research Council
- Center for Innovative Medicine